We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Home Cervical Cancer Testing May Replace Pap Tests

By HospiMedica International staff writers
Posted on 18 Nov 2019
A new study suggests that home screening could bring down the rates of cervical cancer and associated deaths.

Developed at Queen Mary, University of London (QMUL; United Kingdom), the new kit is a triage classifier that aids detection of early precancerous change, known as cervical intraepithelial neoplasia (CIN) grade 2 and above (CIN2+). More...
The test is based on the detection of DNA methylation of human papilloma virus (HPV) HPV16, HPV18, HPV31, HPV33, and the human gene EPB41L3, collectively known as S5. For the study, the researchers compared S5 classifier results in 503 HPV positive women who self-collected vaginal and urine samples.

The results revealed that S5 had a good, statistically significant separation between
“We demonstrated that S5 can be successfully amplified in urine and vaginal self-collected samples and that the classifier is able to correctly identify CIN2+ women,” concluded lead author Belinda Nedjai, PhD, and colleagues of the molecular epidemiology research team. “The advantages of a DIY kit are obvious: more HPV positive women will test themselves, perhaps repeatedly, thus enhancing the chances of picking up more cervical cancers at an early stage, when they are potentially curable. It would also save doctor time since it is based on self-testing.”

“This is exciting research that shows it's possible to detect cervical pre-cancer that is at high risk of developing into invasive cancer in urine and vaginal samples collected by women, in the comfort and privacy of their own homes,” commented Manuel Rodriguez-Justo, MD, of University College London (UCL, United Kingdom). “This has the potential to revolutionize the way a positive HPV test is followed up, as well as making it easier for women in countries with no cervical cancer screening program to be tested.”

DNA testing for HPV has gained widespread acceptance as an additional cervical cancer screening tool and as follow-up to abnormal changes detected with a PAP smear. There are now several such DNA HPV tests that can detect either the majority of the high-risk types of HPV or specific subtypes, such as HPV-16 and HPV-18. It is generally not recommended for screening women younger than age 30 since infections with HPV are relatively common in this age group, and often resolve without treatment or complications.

Related Links:
Queen Mary, University of London


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Blood Gas Analyzer
i-Check200
Patient Preoperative Skin Preparation
BD ChloraPrep
X-Ray Generator
Advantage Plus Generators
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Credit: MedUni Wien/Houdek

New Surgical Technique Enlarges Aortic Root for Larger Valve Implantation

When replacing a diseased aortic valve, a small aortic root can prevent surgeons from implanting a prosthesis large enough for the patient’s body size. This can lead to patient-prosthesis mismatch, causing... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.